Changes in absolute flow, myocardial resistance and FFR after chronic total occlusion percutaneous coronary intervention
- PMID: 36722201
- PMCID: PMC10242660
- DOI: 10.4244/EIJ-D-22-00694
Changes in absolute flow, myocardial resistance and FFR after chronic total occlusion percutaneous coronary intervention
Abstract
Background: Randomised studies of percutaneous coronary intervention (PCI) in patients with chronic total occlusion (CTO) have shown inconsistent outcomes, suggesting incomplete understanding of this cohort and their coronary physiology. To address this shortcoming, we designed a prospective observational study to measure the recovery of absolute coronary blood flow following successful CTO PCI Aims: We sought to identify patient and procedural characteristics associated with a favourable physiological outcome after CTO PCI.
Methods: Consecutive patients with a CTO subtending viable myocardium underwent PCI utilising contemporary techniques and the hybrid algorithm. Immediately after PCI, and at 3-month follow-up, physiological measurements were performed utilising continuous thermodilution.
Results: A total of 81 patients were included with a mean age of 63.6±8.9 years, and 66 (81.5%) were male. Physiological measurements of absolute coronary blood flow in the CTO vessel increased by 30% (p<0.001) and microvascular resistance reduced by 16% (p<0.001) from immediately post-CTO PCI to follow-up assessment. Fractional flow reserve increased by 0.02 (p=0.015) in the same period. Prior coronary artery bypass graft (CABG) and a higher estimated glomerular filtration rate (eGFR) were associated with a larger change in absolute flow. An extraplaque strategy was associated with a smaller change in absolute flow.
Conclusions: Post-CTO PCI, there is a continued augmentation in absolute coronary blood flow and reduction in microvascular resistance from baseline to follow-up at 3 months. Prior CABG and a higher baseline eGFR were predictors of a larger change in absolute coronary flow, whilst an extraplaque final wire path strategy predicted a smaller change. Lastly, the patient characteristics and comorbidities had a larger influence than procedural factors on the observed change in absolute flow.
Conflict of interest statement
C. Cook is a consultant for Philips, Boston Scientific, and Viz.ai; has received an institutional grant from Edwards Lifesciences; and has equity in Cerebria. N. Pijls has received institutional grants from Abbott and Hexacath; is a consultant for Abbott and GE Healthcare; and has minor equities in Philips, ASML, and HeartFlow. T. Keeble has received research grants from Boston Scientific, Volcano, Terumo, and Abbott Vascular. G. Karamasis has received honoraria from Abbott Vascular; and has received a research grant from Abbott Vascular. J. Davies has received a research grant from Medtronic. The other authors have no conflicts of interest to declare.
Figures
References
-
- Nijjer SS, Petraco R, van de, Sen S, van Lavieren, Foale RA, Meuwissen M, Broyd C, Echavarria-Pinto M, Al-Lamee R, Foin N, Sethi A, Malik IS, Mikhail GW, Hughes AD, Mayet J, Francis DP, Di Mario, Escaned J, Piek JJ, Davies JE. Change in coronary blood flow after percutaneous coronary intervention in relation to baseline lesion physiology: results of the JUSTIFY-PCI study. Circ Cardiovasc Interv. 2015;8:e001715. - PMC - PubMed
-
- Werner GS, Martin-Yuste V, Hildick-Smith D, Boudou N, Sianos G, Gelev V, Rumoroso JR, Erglis A, Christiansen EH, Escaned J, di Mario, Hovasse T, Teruel L, Bufe A, Lauer B, Bogaerts K, Goicolea J, Spratt JC, Gershlick AH, Galassi AR, Louvard Y EUROCTO trial investigators. A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions. Eur Heart J. 2018;39:2484–93. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
